iifl-logo

Concord Drugs Ltd Share Price Live

Add as a Preferred Source on Google
₹80.75
(-0.30%)
May 20, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹80.05
  • Day's High₹82.34
  • 52 Wk High₹92.52
  • Prev. Close₹80.99
  • Day's Low₹79
  • 52 Wk Low ₹29
  • Turnover (lac)6.7
  • P/E202.48
  • Face Value₹10
  • Book Value₹34.87
  • EPS0.4
  • Mkt. Cap (Cr.)₹106.39
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Concord Drugs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹80.05

Prev. Close

₹80.99

Turnover(Lac.)

₹6.7

Day's High

₹82.34

Day's Low

₹79

52 Week's High

₹92.52

52 Week's Low

₹29

Book Value

₹34.87

Face Value

₹10

Mkt Cap (₹ Cr.)

106.39

P/E

202.48

EPS

0.4

Divi. Yield

0

Concord Drugs Ltd Corporate Action

15 Sep 2025

12:00 AM

AGM

Announcement Date: 15 Sep, 2025

arrow

8 Sep 2025

12:00 AM

BookCloser

arrow

2 Feb 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

9 Jul 2025

12:00 AM

EGM

arrow

Concord Drugs Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Concord Drugs Ltd SHAREHOLDING SNAPSHOT

20 May, 2026|09:55 PM
Mar-2026Dec-2025Nov-2025Sep-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 54.39%

Foreign: 0.00%

Indian: 54.39%

Non-Promoter- 45.60%

Institutions: 0.00%

Non-Institutions: 45.60%

Custodian: 0.00%

Read More
Share PriceShare Price

Concord Drugs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

10

10

9.88

8.74

Preference Capital

0

0

0

0

Reserves

24.11

23.82

21.82

19.62

Net Worth

34.11

33.82

31.7

28.36

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

51.35

51.33

51.79

57.48

yoy growth (%)

0.03

-0.88

-9.9

13.43

Raw materials

-42.17

-42.57

-43.29

-46.1

As % of sales

82.12

82.93

83.59

80.19

Employee costs

-3.75

-3.5

-1.97

-2.8

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.52

0.45

0.63

0.64

Depreciation

-1.36

-1.46

-2.4

-2.58

Tax paid

-1.01

-0.12

-0.31

-0.48

Working capital

5.74

1.76

11.4

-13.41

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

0.03

-0.88

-9.9

13.43

Op profit growth

-3.71

-30.16

-13.02

-33.22

EBIT growth

-2.55

-20.71

-16.11

-45.68

Net profit growth

899.6

1.23

103.25

-90.87

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

45.24

44.92

52.08

58.96

Excise Duty

0

0

0

0

Net Sales

45.24

44.92

52.08

58.96

Other Operating Income

0.01

0.01

0.01

0.1

Other Income

0

0

0

0

Concord Drugs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,880.5

103.384,51,194.94705.440.855,651.2199.24

Divis Laboratories Ltd

DIVISLAB

6,893.2

71.131,82,992.85980.432,578578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,429.85

67.131,49,926.255770.142,547249.82

Cipla Ltd

CIPLA

1,399.5

30.551,13,051.69384.640.933,840.92423.38

Dr Reddys Laboratories Ltd

DRREDDY

1,321.9

34.261,10,333.3-219.40.613,802.6375.78

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Concord Drugs Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / M D / Promoter

S Nagi Reddy

ED / WTD / CFO / Promoter

Koni Reddy

WTD & Executive Director

S. Manoj Kumar Reddy

Independent Non Exe. Director

K Ramchandra Reddy

Independent Non Exe. Director

Summela Kasu

Independent Non Exe. Director

S. Nagavenkata Hareesh

Independent Non Exe. Director

Satyam Reddy Gopidi

Company Sec. & Compli. Officer

Namratha

Registered Office

Survey No 249 Brahmanapally V,

Hayathnagar M,

Telangana - 501511

Tel: 91-40-24036379

Website: http://www.concorddrugs.in

Email: concorddrugsltd@gmail.com

Registrar Office

1-2-285 Domalguda,

Hyderabad - 500 029

Tel: 91-040-27638111/4445

Website: www.aarthiconsultants.com

Email: info@aarthiconsultants.com

Summary

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenter...
Read More

Reports by Concord Drugs Ltd

Company FAQs

What is the Concord Drugs Ltd share price today?

The Concord Drugs Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹80.75 today.

What is the Market Cap of Concord Drugs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Concord Drugs Ltd is ₹106.39 Cr. as of 20 May ‘26

What is the PE and PB ratio of Concord Drugs Ltd?

The PE and PB ratios of Concord Drugs Ltd is 202.48 and 2.32 as of 20 May ‘26

What is the 52 Week High and Low of Concord Drugs Ltd?

The 52-week high/low is the highest and lowest price at which a Concord Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Concord Drugs Ltd is ₹29 and ₹92.52 as of 20 May ‘26

What is the CAGR of Concord Drugs Ltd?

Concord Drugs Ltd's CAGR for 5 Years at 18.78%, 3 Years at 41.59%, 1 Year at 151.29%, 6 Month at -2.67%, 3 Month at -2.71% and 1 Month at -3.32%.

What is the shareholding pattern of Concord Drugs Ltd?

The shareholding pattern of Concord Drugs Ltd is as follows:
Promoters - 54.39 %
Institutions - 0.00 %
Public - 45.61 %

QUICKLINKS FOR Concord Drugs Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.